Compounds > imipenem, anhydrous
Page last updated: 2024-08-26

imipenem, anhydrous and Autosomal Recessive Chronic Granulomatous Disease

imipenem, anhydrous has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boiron, P; Crisinel, PA; Hagerman, A; Posfay-Barbe, KM; Rodríguez-Nava, V1
Matsumoto, S; Narita, M; Shibata, M; Togashi, T; Tomizawa, K1

Other Studies

2 other study(ies) available for imipenem, anhydrous and Autosomal Recessive Chronic Granulomatous Disease

ArticleYear
Imipenem-resistant Nocardia cyriacigeorgica infection in a child with chronic granulomatous disease.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:3

    Topics: Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Granulomatous Disease, Chronic; Humans; Imipenem; Male; Microbial Sensitivity Tests; Nocardia; Nocardia Infections

2011
Steroid therapy for bronchopneumonia in chronic granulomatous disease.
    Acta paediatrica Japonica : Overseas edition, 1991, Volume: 33, Issue:2

    Topics: Adolescent; Bronchopneumonia; Cefazolin; Drug Therapy, Combination; Granulomatous Disease, Chronic; Humans; Imipenem; Male; Prednisolone

1991